Sticker Pad Containing Essential Oil in Volunteer With High Blood Pressure

Efficacy and Safety of Sticker Pad Containing Essential Oil in Volunteer With High Blood Pressure

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT05808556

Enrollment

Registered

2023-04-11

Start date

2020-10-02

Completion date

2021-09-20

Last updated

2023-04-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

High Blood Pressure

Brief summary

The aims of the study were to evaluate efficacy and safety of the sticker pads containing lavender and ylang ylang oil in high blood pressure volunteers

Detailed description

High blood pressure volunteers were divided into the sticker group or the placebo group. The volunteers attached the pad to their shirt for 3, 7, 10, and 14 days. Blood pressure, pulse rate, adverse reactions, and satisfaction were investigated.

Interventions

DEVICESticker pads containing lavender and ylang ylang oil

The sticker pad group attached an sticker pad (0.3% lavender oil and 0.7% ylang ylang oil) to their shirt, close to the right side of the neck, for 14 days,

DEVICEPlacebo

The placebo group attached a sticker pad without lavender and ylang ylang oil to their shirt, close to the right side of the neck, for 14 days.

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Masking

SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* age more than 18 years * systolic blood pressure of more than 130 mmHg but less than 160 mmHg or diastolic blood pressure more than 80 mmHg but less than 100 mmHg * no hypertensive medicine * no dermatological diseases, immunocompromised diseases, seizures, asthma, or respiratory diseases

Exclusion criteria

* an unstable condition of other diseases * olfactory problems * pregnancy * lactation

Design outcomes

Primary

Measure	Time frame	Description
Systolic blood pressure	14 days	Measure systolic blood pressure in mmHg
Diastolic blood pressure	14 days	Measure diastolic blood pressure in mmHg
Pulse rate	14 days	Measure pulse rate in beats/minutes

Secondary

Measure	Time frame	Description
adverse reactions of the respiratory tract, skin, gastrointestinal tract, eye, and central nervous system	14 days	Using a score of 0 to 3, following an increase of severity
Satisfaction of the product	14 days	Using a visual analogue scale, 0 means not satisfied, 10 means very satisfied

Countries

Thailand

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026